FPIs pulled out about USD 17.5 billion from Indian equities in 2025, the highest annual outflow on record in absolute terms.

As a public health scientist, I have learned that firm prescriptions rarely capture life’s complexity,” Robert M. Kaplan ...

The iShares Edge MSCI USA Value Factor ETF delivered a stellar 34.03% total return in 2025, far outpacing the S&P 500's 18.91 ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

FDA introduces the “chain of risk” framework to regulate tobacco products by harm level, sparking global debate.

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...

How brands use small batch and limited edition language in fashion and lifestyle, and why production numbers can reveal a gap ...

Diabetes mellitus could drain tens of trillions from the global economy, with informal caregiving emerging as the largest ...

U.S. banks enter 2026 with a solid operating backdrop, but limited upside for stocks after a strong run. The banks are well positioned defensively if equity markets turn volatile, but investors should ...

Commonly prescribed sleep medications such as zolpidem are not associated with a meaningful increase in the overall risk for ...

State-owned enterprises (SOEs) are steadily losing financial strength, with the value of their assets and revenues declining ...